165 related articles for article (PubMed ID: 2524399)
1. Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion.
Di Renzo G; Amoroso S; Taglialatela M; Canzoniero L; Basile V; Fatatis A; Annunziato L
Eur J Pharmacol; 1989 Mar; 162(2):371-3. PubMed ID: 2524399
[TBL] [Abstract][Full Text] [Related]
2. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
3. Effect of selective serotonin (5-HT) agonists and 5-HT2 antagonist on prolactin secretion.
Van de Kar LD; Lorens SA; Urban JH; Bethea CL
Neuropharmacology; 1989 Mar; 28(3):299-305. PubMed ID: 2524677
[TBL] [Abstract][Full Text] [Related]
4. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
5. Receptor subtypes mediating facilitation by serotonin of excitability of spinal motoneurons.
Jackson DA; White SR
Neuropharmacology; 1990 Sep; 29(9):787-97. PubMed ID: 2149874
[TBL] [Abstract][Full Text] [Related]
6. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.
Backus LI; Sharp T; Grahame-Smith DG
Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholine release from rat hippocampal slices is modulated by 5-hydroxytryptamine.
Maura G; Fedele E; Raiteri M
Eur J Pharmacol; 1989 Jun; 165(2-3):173-9. PubMed ID: 2528465
[TBL] [Abstract][Full Text] [Related]
8. Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists.
Fuller RW; Snoddy HD
Neuroendocrinology; 1990 Aug; 52(2):206-11. PubMed ID: 2148812
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of serotonin (5-HT1A and 5-HT2) agonists and antagonists on renin and corticosterone secretion.
Lorens SA; Van de Kar LD
Neuroendocrinology; 1987 Apr; 45(4):305-10. PubMed ID: 2952898
[TBL] [Abstract][Full Text] [Related]
10. Chronic 5-HT2 receptor antagonist treatment alters 5-HT1A autoregulatory control of 5-HT release in rat brain in vivo.
Kidd EJ; Leysen JE; Marsden CA
J Neurosci Methods; 1990 Sep; 34(1-3):91-8. PubMed ID: 1701842
[TBL] [Abstract][Full Text] [Related]
11. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
Tricklebank MD; Neill J; Kidd EJ; Fozard JR
Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
[TBL] [Abstract][Full Text] [Related]
12. Repeated cocaine exposure inhibits the adrenocorticotropic hormone response to the serotonin releaser d-fenfluramine and the 5-HT1A agonist, 8-OH-DPAT.
Levy AD; Li Q; Van de Kar LD
Neuropharmacology; 1994; 33(3-4):335-42. PubMed ID: 7984271
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
Bagdy G; Sved AF; Murphy DL; Szemeredi K
Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
[TBL] [Abstract][Full Text] [Related]
14. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors.
Rittenhouse PA; Levy AD; Li Q; Bethea CL; Van de Kar LD
Endocrinology; 1993 Aug; 133(2):661-7. PubMed ID: 8344205
[TBL] [Abstract][Full Text] [Related]
15. Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat.
Dugovic C; Wauquier A; Leysen JE; Marrannes R; Janssen PA
Psychopharmacology (Berl); 1989; 97(4):436-42. PubMed ID: 2524856
[TBL] [Abstract][Full Text] [Related]
16. A central serotonin receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, has different effects on prolactin secretion in male and female rats.
Carlsson M; Eriksson E
Acta Pharmacol Toxicol (Copenh); 1986 Apr; 58(4):297-302. PubMed ID: 2940798
[TBL] [Abstract][Full Text] [Related]
17. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
[TBL] [Abstract][Full Text] [Related]
18. The role of putative 5-HT1A and 5-HT1B receptors in the control of feeding in rats.
Bendotti C; Samanin R
Life Sci; 1987 Aug; 41(5):635-42. PubMed ID: 2955189
[TBL] [Abstract][Full Text] [Related]
19. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
20. Effects of MDL 73005EF on central pre- and postsynaptic 5-HT1A receptor function in the rat in vivo.
Gartside SE; Cowen PJ; Hjorth S
Eur J Pharmacol; 1990 Dec; 191(3):391-400. PubMed ID: 1964908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
